The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 27, 2019

Filed:

Jan. 12, 2017
Applicant:

Abvitro Llc, Boston, MA (US);

Inventors:

Francois Vigneault, Seattle, WA (US);

Adrian Wrangham Briggs, Seattle, WA (US);

Stephen J. Goldfless, Seattle, WA (US);

Brian J. Belmont, Seattle, WA (US);

Assignee:

AbVitro LLC, Seattle, WA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12P 19/34 (2006.01); G01N 33/569 (2006.01); C12Q 1/6804 (2018.01); C12Q 1/6869 (2018.01); C12N 15/10 (2006.01); C12Q 1/6881 (2018.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
G01N 33/56972 (2013.01); C12N 15/1065 (2013.01); C12Q 1/6804 (2013.01); C12Q 1/6869 (2013.01); C12Q 1/6881 (2013.01); G01N 33/6872 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/7051 (2013.01); G01N 2333/70514 (2013.01); G01N 2333/70517 (2013.01); G01N 2333/70539 (2013.01); G01N 2458/10 (2013.01);
Abstract

Provided herein are methods and compositions for single cell characterization using affinity-oligonucleotide conjugates, including tetramer-oligonucleotide conjugates (e.g., pMHC-oligonucleotide). In some aspects, such methods may comprise the steps of: forming a vessel comprising an affinity-oligonucleotide conjugate and a T cell; attaching a vessel barcoded polynucleotide or complement thereof to: (a) an oligonucleotide portion of a pMHC-oligonucleotide conjugate, and (b) a T cell receptor (TCR) polynucleotide originating from the T cell; and sequencing the oligonucleotide portion or a complement thereof and the TCR polynucleotide or a complement thereof. Additional methods provided herein include determining the binding affinity of a T cell receptor (TCR) to a pMHC-oligonucleotide. Compositions of the present invention encompass a plurality of vessels, wherein a vessel of the plurality of vessels may comprise a single T cell; and a vessel barcoded polynucleotide, wherein the vessel may further comprise a pMHC-oligonucleotide conjugate.


Find Patent Forward Citations

Loading…